New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2014
07:51 EDTMRMindray Medical price target lowered to $42 from $50 at Oppenheimer
Oppenheimer cut its price target on Mindray Medical after the company reported stronger than expected Q4 results but provided lower than expected FY14 net income guidance. The firm keeps an Outperform rating on the stock.
News For MR From The Last 14 Days
Check below for free stories on MR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for MR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use